Literature DB >> 7350874

Somatostatin inhibits diarrhea in the carcinoid syndrome.

K Dharmsathaphorn, R S Sherwin, S Cataland, B Jaffe, J Dobbins.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7350874     DOI: 10.7326/0003-4819-92-1-68

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  23 in total

1.  Mechanisms underlying modulation of monocarboxylate transporter 1 (MCT1) by somatostatin in human intestinal epithelial cells.

Authors:  Seema Saksena; Saritha Theegala; Nikhil Bansal; Ravinder K Gill; Sangeeta Tyagi; Waddah A Alrefai; Krishnamurthy Ramaswamy; Pradeep K Dudeja
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-11       Impact factor: 4.052

2.  Pre-treatment with somatostatin in the anaesthetic management of a patient with carcinoid syndrome.

Authors:  W C Parris; J A Oates; J Kambam; R Shmerling; J F Sawyers
Journal:  Can J Anaesth       Date:  1988-07       Impact factor: 5.063

3.  The pentagastrin test in the diagnosis of the carcinoid syndrome. Blockade of gastrointestinal symptoms by ketanserin.

Authors:  H Ahlman; A Dahlström; K Grönstad; L E Tisell; K Oberg; M J Zinner; B M Jaffe
Journal:  Ann Surg       Date:  1985-01       Impact factor: 12.969

4.  Substance P-induced intestinal secretion of water and electrolytes.

Authors:  D McFadden; M J Zinner; B M Jaffe
Journal:  Gut       Date:  1986-03       Impact factor: 23.059

Review 5.  Recent advances in pancreatic hormone research.

Authors:  R G Long
Journal:  Postgrad Med J       Date:  1983-05       Impact factor: 2.401

6.  Structure-activity relationships of somatostatin analogs in the rabbit ileum and the rat colon.

Authors:  L E Rosenthal; D J Yamashiro; J Rivier; W Vale; M Brown; K Dharmsathaphorn
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

7.  Effect of a long acting somatostatin analogue SMS 201-995 on jejunostomy effluents in patients with severe short bowel syndrome.

Authors:  K Ladefoged; K C Christensen; J Hegnhøj; S Jarnum
Journal:  Gut       Date:  1989-07       Impact factor: 23.059

Review 8.  Octreotide in the treatment of refractory diarrhoea and intestinal fistulae.

Authors:  M J Farthing
Journal:  Gut       Date:  1994       Impact factor: 23.059

9.  Treatment of secretory diarrhea in AIDS with the somatostatin analogue SMS 201-995.

Authors:  H S Füessl; W G Zoller; M M Kochen; J R Bogner; B Heinrich; A Matuschke; F D Goebel
Journal:  Klin Wochenschr       Date:  1989-04-17

10.  Update on management of midgut neuroendocrine tumors.

Authors:  Amir Mehrvarz Sarshekeh; Daniel M Halperin; Arvind Dasari
Journal:  Int J Endocr Oncol       Date:  2016-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.